No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
LPTX240621C7000
- 0.25
- 0.000.00%
15min DelayClose Jun 18 09:44 ET
0.00High0.00Low
0.25Open0.25Pre Close0 Volume43 Open Interest7.00Strike Price0.00Turnover1440.42%IV273.71%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type0.2921Delta0.1546Gamma7.76Leverage Ratio-0.1605Theta0.0000Rho2.27Eff Leverage0.0005Vega
Intraday
- 5D
- Daily
News
Leap and SWTCH Energy Launch New Virtual Power Plant Solutions for Multi-Tenant EV Charging Infrastructure
New partnership will scale innovative grid flexibility solutions to underserved multifamily property marketSAN FRANCISCO & TORONTO--(BUSINESS WIRE)--#EVcharging--Leap, the leading virtual power plant
Buy Rating Affirmed for Leap Therapeutics on Strong Trial Prospects and Solid Financials
Leap Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Leap Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Lowers Price Target to $5.5
Leap Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 97.13% HC Wainwright & Co. $7 → $5.5 Maintains Buy 03/19/2024 222.58% Baird $11 → $9 Maintains
Leap Therapeutics Inc (LPTX) Q1 2024 Earnings: Financial Resilience Amidst Clinical Progress
Comments
$Leap Therapeutics(LPTX.US$ Leap Therapeutics 13G Filing Shows Gilead Sciences, Inc. Reported A 13.9% Stake In The Co As Of April 10, 2024![]()
1
43
April 11
Leap Therapeutics announced it has entered into a securities purchase agreement with a select group of institutional investors to issue and sell an aggregate of 12.66M shares of its common stock at a price of $2.82 per share and pre-funded warrants to purchase 1.52M shares of common stock at a price of $2.819 per share of common stock issuable upon exercise of the pre-funded warrants, in a private placement. Leap anticipates the gross proceeds from the private placement will be approxi...
Leap Therapeutics announced it has entered into a securities purchase agreement with a select group of institutional investors to issue and sell an aggregate of 12.66M shares of its common stock at a price of $2.82 per share and pre-funded warrants to purchase 1.52M shares of common stock at a price of $2.819 per share of common stock issuable upon exercise of the pre-funded warrants, in a private placement. Leap anticipates the gross proceeds from the private placement will be approxi...
$Leap Therapeutics(LPTX.US$ Was just curious if any followers caught this? If so congrats and hope you secured profits 🥂💵
1
$Leap Therapeutics(LPTX.US$
NEWS
LEAP THERAPEUTICS ANNOUNCES $40 MILLION PRIVATE PLACEMENT
INTENDS TO USE NET PROCEEDS FROM FINANCING TO FUND CONTINUED DEVELOPMENT OF ITS LEAD MONOCLONAL ANTIBODY PROGRAM, DKN-01
NEWS
LEAP THERAPEUTICS ANNOUNCES $40 MILLION PRIVATE PLACEMENT
INTENDS TO USE NET PROCEEDS FROM FINANCING TO FUND CONTINUED DEVELOPMENT OF ITS LEAD MONOCLONAL ANTIBODY PROGRAM, DKN-01
Read more
Jaguar8 : Love it
TrytosaveabitOP Jaguar8: Right! What’s Gilead up to? Hehehe
Jaguar8 TrytosaveabitOP: I sense they will eventually buy this out
买跌不追涨 : You can rest early today, don't be so tired. Have a nice weekend
BelleWeather : Interesting choice. I’m going to do DD with a focus on the science. I hope it pans out and they get bought out.
View more comments...